The use of CBD oil for Alzheimer’s disease and dementia

New Post Public Reply Private Reply Replies (2) Message Board
Kgem
2,097
The use of CBD oil for Alzheimer’s disease and dementia is on the rise—and for good reason.

Alzheimer’s disease impacts an estimated 1 in 10 people over 65. It is a cruel illness, progressively disrupting the neural pathways which control memory, speech, and movement, sometimes causing instances of aggression and agitation in the sufferer.

With no current medical treatments for combating the illness, many sufferers of Alzheimer’s-related dementia and their caregivers are looking to alternatives like CBD oil to potentially provide a better quality of life.

Benefits of Using CBD Oil for Dementia and Alzheimer’s Disease

There is currently no cure for Alzheimer’s disease and dementia, although researchers are constantly looking for new pathways to explore, and CBD oil may provide the next breakthrough.

Current treatment options include talk therapy and person-centered care to reduce some of the stress, anxiety, and agitation associated with dementia. In addition, cholinesterase inhibitors are often prescribed to improve memory and cognition. Some cholinesterase inhibitors are metabolized via CYP450, so there could be an interaction with CBD.

Unfortunately, these cholinesterase inhibitors come with a range of negative side effects, including a loss of appetite, nausea, vomiting, and diarrhea, which, when experienced in patients who are elderly or infirm, can lead to serious health complications.

CBD oil, on the other hand, does not produce these side effects. In fact, The World Health Organization (WHO) states that “no public health problems… have been associated with the use of pure CBD [oil].”

This means CBD oil may be a viable treatment option for someone struggling to beat or avoid the side effects of conventional Alzheimer’s disease and dementia medications.

The decision to take CBD oil is a personal one and should be made having conducted full research on the subject. Many doctors and physicians are now aware of the potential benefits of CBD oil, and are well positioned to advise on how it may work as part of your own treatment plan. If you’re seriously considering CBD oil as a treatment option, speak to your doctor first, as CBD has been known to interact with certain medications (e.g. antidepressants, antihistamines, and even aspirin).

If, however, you find that your doctor is not able to provide satisfactory information, you may wish to consult a naturopathic doctor who has an in-depth understanding of CBD oil for medicinal use.

Effectiveness of Using CBD Oil in Treating Symptoms of Alzheimer’s Disease and Dementia

Cannabidiol, or CBD, is a phytocannabinoid that interacts with the body’s own endocannabinoid system to produce a variety of health benefits. Unlike the THC cannabinoid, CBD has no intoxicating properties and therefore does not elicit the “high” associated with marijuana use. Instead, patients report a wealth of improvements to health, with hundreds of studies currently underway to explore its potential uses.

There are three main ways CBD oil has been found to improve the health of those suffering from dementia: reducing oxygenation (CBD can increase blood flow and reduce oxidative damage), reducing inflammation, and stimulating and protecting the brain. CBD oil is also believed to reduce the anxiety and stress that may trigger episodes of aggression.

When the brain’s immune cells are unable to clear blockages, which are common in dementia, an inflammatory reaction is triggered. This inflammation has been shown to worsen symptoms of Alzheimer’s disease. Inflammation is one of the main afflictions CBD oil has been shown to reduce, with a 2017 study reporting that “CBD may be a promising candidate for AD [Alzheimer’s disease] therapy by inhibiting oxidative stress and neuroinflammation.”

The inflammation that occurs in the brain due to Alzheimer’s disease also provokes a release of oxygen. As the oxygen levels within the brain cells rise, functions such as memory decrease. As CBD oil is also an antioxidant, it’s been shown to reduce this effect, as reported in a 2010 study on CBD oil and its effect on oxidative stress.

The brain cell count in Alzheimer’s patients is often shown to undergo a steady decline, reducing cognitive function and leaving destroyed pathways in their wake. CBD oil has been shown in numerous studies to not only prevent the destruction of brain cells, but promote regrowth, or neurogenesis.

At the end of the day, you should know that there seem to be no clinical trials assessing the efficiency of CBD in Alzheimer's patients. It is not possible to say how animal and in-vivo studies translate to humans.

How to Use CBD Oil for Alzheimer’s Disease and Dementia

There are many ways to take CBD oil for dementia, with the decision ultimately coming down to personal preference. While drops, edibles, inhalants, and gummies are all common options, many people using CBD oil for Alzheimer’s and dementia may prefer to take it in capsule form. A daily capsule can easily be combined with other medications so it’s not easily forgotten. It is also an easy method of consumption for those with limited mobility, who may find the fine motor skills involved in using a dropper more difficult.

When deciding how much CBD oil to take, consult the instructions and recommendation on the product you purchased.

If you’re having trouble determining a starting dosage, we here at CBD Oil Review have analyzed hundreds of products and come up with a standard serving suggestion:

The CBD Oil Review Serving Standard is 25mg of CBD, taken twice daily.

If you are not getting your desired results from this amount, we recommend increasing the serving size by 25mg every 3-4 weeks until you find relief.

Remember, when it comes to dosage, there is no standard for CBD oil. Because all people are different, there will be some variation in the amount needed to find relief. 


https://cbdoilreview.org/diseases-conditions/...-dementia/





Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 33

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 37

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 29

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 40

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from APA Corporation's Q3 2024 Financial Update

Updated Category News Views 291

Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...

Continue Reading
Exploring the Growing Trends in the US Coffee Market to 2034

Updated Category News Views 394

Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...

Continue Reading
Insights into Great Lakes Dredge & Dock's Upcoming Earnings

Updated Category News Views 125

Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...

Continue Reading
Calmére Estate Winery Sold, Signaling Growth in Napa Valley

Updated Category News Views 306

Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...

Continue Reading
Mr. Splash Car Wash Partners with NBA Stars for Growth

Updated Category News Views 204

Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...

Continue Reading